Results 11 to 20 of about 44,151 (306)
Frontiers in Immunology, 2021 BackgroundRosacea, a chronic inflammatory skin disorder etiologically associated with immune cells and the antibacterial peptide cathelicidin LL-37, can be effectively treated by oral carvedilol administration.ObjectiveTo investigate the molecular ...
Jiawen Zhang +11 more
doaj +2 more sources
Is carvedilol superior to propranolol in patients with cirrhosis with portal hypertension: a systematic and meta-analysis [PDF]
Drugs in ContextBackground: Carvedilol has shown greater potency than propranolol as a β-blocker in managing cardiac conditions. However, its efficacy in reducing portal hypertension (PHTN) in patients with cirrhosis remains unclear.
Siddheesh Rajpurohit +4 more
doaj +2 more sources
Inhibitory effect of carvedilol on bedaquiline metabolism in vitro and in vivo [PDF]
PeerJBedaquiline has recently been approved for the treatment of multidrug-resistant tuberculosis. Carvedilol is a cardiovascular medication extensively used in the treatment of heart failure and hypertension.
Qingqing Li +4 more
doaj +3 more sources
Endothelial function is unaffected by changing between carvedilol and metoprolol in patients with heart failure-a randomized study [PDF]
Cardiovascular Diabetology, 2011 Background Carvedilol has been shown to be superior to metoprolol tartrate to improve clinical outcomes in patients with heart failure (HF), yet the mechanisms responsible for these differences remain unclear.
Køber Lars +8 more
doaj +5 more sources
Effect of Carvedilol on Survival in Severe Chronic Heart Failure [PDF]
New England Journal of Medicine, 2001 Milton Packer +13 more
openalex +2 more sources
Carvedilol in the treatment of chronic heart failure: Lessons from The Carvedilol Or Metoprolol European Trial [PDF]
Vascular Health and Risk Management, 2007 Britt Kveiborg, Atheline Major-Petersen, Buris Christiansen, Christian Torp-PedersenDepartment of Cardiology, Bispebjerg University Hospital, Copenhagen, DenmarkAbstract: Beta-blockers have been shown to improve survival in patients with chronic heart ...
Britt Kveiborg +3 more
doaj +3 more sources
Liver international (Print), 2023 Portal hypertension (PH) is the most common complication ofcirrhosis and represents the main driver of hepatic decompensation. The overarching goal of PH treatments in patients with compensated cirrhosis is to reduce the risk of hepatic decompensation (i.
L. Turco +3 more
semanticscholar +1 more source
Cancers, 2023 Simple Summary Benzo(a)pyrene is a ubiquitously present environmental contaminant that induces lung cancer after being converted into active metabolites via aryl hydrocarbon receptor (AhR)-mediated metabolic activation.
A. Shahid +6 more
semanticscholar +1 more source
Research in Pharmaceutical Sciences, 2022 Background and purpose: The study was aimed at validating a simple, rapid, and low-cost LC-MS/MS method for carvedilol and 4/-hydroxyphenyl carvedilol assay in human plasma. The validated method was applied to investigate the pharmacokinetics after a low
Wanna Eiamart +5 more
doaj +1 more source
Pharmaceutics, 2023 Solid dosage forms based on hypromellose (HPMC) with prolonged/extended drug release are very important from the research and industrial viewpoint. In the present research, the influence of selected excipients on carvedilol release performance from HPMC ...
Tadej Ojsteršek +2 more
doaj +1 more source